This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Wave Life Sciences shared updated results from a Phase 2 trial of its exon-skipp...
Many people are dealing with a medication mess. They get prescriptions from diff...
If marketing’s participation isn’t already incorporated into a company’s officia...
One of the biotech industry's most well-funded cell and gene therapy companies h...
Plus, news about Tribune Therapeutics and Leap Therapeutics: Humacyte’s $50M...
The following is a guest article by Josh Rosaasen, Chief Operating Officer at Lo...
While high-acuity options must remain for those that need stronger interventions...
The Endpoints News Slack chat is back for 2025, and we're starting with a 32-yea...
It can be very overwhelming scrolling though job board after job board in search...
Decades ago, Amber Salzman remembers feeling like there was nothing she could do...
The Trump administration's threatened tariffs on Europe would be painful for the...
In the 21st century, we are fortunate to benefit from perpetual advances in medi...
The Senate on Tuesday voted 56-44 to confirm Johns Hopkins researcher Marty Maka...
Apellis Pharmaceuticals and Astellas Pharma have the first two FDA-approved ther...
Stanford researcher Jay Bhattacharya has been confirmed as the new head of the N...
What You Should Know: – Roper Technologies has announced a definitive agreement...